Supernus Pharmaceuticals reported $113.24M in Stock for its fiscal quarter ending in September of 2026.





Stock Change Date
Abbott USD 7.34B 22M Sep/2026
ANI Pharmaceuticals USD 136.41M 6.74M Sep/2026
Aurora Cannabis CAD 187.54M 12.47M Jun/2026
Bristol-Myers Squibb USD 2.7B 33M Sep/2026
Canopy Growth CAD 107.46M 3.06M Jun/2026
Cara Therapeutics USD 900K 0 Mar/2025
Corcept Therapeutics USD 11.91M 1.28M Sep/2026
Eisai JPY 272.61B 15.06B Sep/2026
Eli Lilly USD 18.19B 1.4B Sep/2026
Novo Nordisk DKK 45.65B 21.26B Jun/2025
Pacira USD 3.83B 3.69B Sep/2026
Perrigo USD 1.01B 50.7M Sep/2026
Pfizer USD 10.02B 77M Sep/2026
Supernus Pharmaceuticals USD 113.24M 6.22M Sep/2026
United Therapeutics USD 201.9M 8.1M Sep/2026
Xeris Pharmaceuticals USD 76.92M 4M Sep/2026